Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Carmelo Gurnari, Hussein Awada, Simona Pagliuca, Danai Dima, Fauzia Ullah, Naomi Kawashima, Yasuo Kubota, Ceylan Colak, Valeria Visconte, Bhumika J. Patel, Vikram Dhillon, Naimisha Marneni, Suresh Kumar Balasubramanian, Ashwin Kishtagari, Taha Bat, Jaroslaw P. Maciejewski

Blood (2024) 144 (2): 145–155.

https://doi.org/10.1182/blood.2024023988

Published: 2024

Journal Articles

Cryo-EM structure and functional basis of prothrombin recognition by a type I antiprothrombin antiphospholipid antibody

Suresh Kumar, Brock Summers, Kathrine Basore, Vittorio Pengo, Robert Flaumenhaft, Nicola Pozzi

Blood (2024) 143 (19): 2005–2011.

https://doi.org/10.1182/blood.2023022942

Published: 2024

Includes: Supplemental data

Journal Articles

Prevalence, Domain Specificity, and Residue Specificity of IgG, IgM, and IgA Anti-β2GPI Antibodies in Tetra-Positive Antiphospholipid Syndrome Patients: Identification of Two Non-Overlapping Epitopes in Domain I of β2GPI

Suresh Kumar, Vittorio Pengo, Nicola Pozzi

Blood (2023) 142 (Supplement 1): 2569.

https://doi.org/10.1182/blood-2023-173472

Published: 2023

Journal Articles

Epigenetic Age Acceleration in Hematological Malignancies: Beyond Chronological Age, Clinical Implications, and Therapeutic Perspectives

Vikram Dhillon, Jeff Aguilar, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 126.

https://doi.org/10.1182/blood-2023-191310

Published: 2023

Journal Articles

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Sushmitha Nanja Reddy, Jeff Aguilar, Lakshmi Bhavani Potluri, Vikram Dhillon, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian, Julie Boerner, Gregory Dyson

Blood (2023) 142 (Supplement 1): 6447.

https://doi.org/10.1182/blood-2023-189972

Published: 2023

Journal Articles

Clinical and Molecular Characteristics of NPM1 MT De Novo AML ( NPM1 MT dnAML) Differ from NPM1 MT therapy-associated AML ( NPM1 MT tAML)

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Gregory Dyson, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 822.

https://doi.org/10.1182/blood-2023-191336

Published: 2023

Journal Articles

Automated Peripheral Smear Recognition and Classification of LGL Leukemia Using Machine Learning

Vikram Dhillon, Jeff Aguilar, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 3668.

https://doi.org/10.1182/blood-2023-191258

Published: 2023

Journal Articles

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 4321.

https://doi.org/10.1182/blood-2023-191331

Published: 2023

Journal Articles

Pomab a Novel Monoclonal Type-I Antiphospholipid Antibody, Reduces Thrombin Generation By Selectively Binding to the Open Form of Prothrombin

Suresh Kumar, Glenn Merrill-Skoloff, Vittorio Pengo, Robert Flaumenhaft, Nicola Pozzi

Blood (2023) 142 (Supplement 1): 1231.

https://doi.org/10.1182/blood-2023-173851

Published: 2023

Journal Articles

Meta-Analysis of Clinicopathological and Biological Characteristics of Myeloid Sarcoma

Jeff Aguilar, Dakshin Padmanabhan, Gregory Dyson, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 3811.

https://doi.org/10.1182/blood-2023-191066

Published: 2023

Journal Articles

The Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit the Growth of MLL-r AML

Md. Hafiz Uddin, Amro Aboukameel, Sharif hasan Siddiqui, Husain Khan, Sahar Bannoura, Abhinav Deol, Jay Yang, Gregory Dyson, Asfar Azmi, Lisa Polin, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 4168.

https://doi.org/10.1182/blood-2023-190638

Published: 2023

Journal Articles

Evaluation of Treatment Outcomes in Adults with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Review and Meta-Analysis

Michael Sandhu, Prashanth Ashok Kumar, Vishnu Suresh Kumar, Osama Batayneh, Sravanthi Venkata Metpalli, Teresa Gentile

Blood (2023) 142 (Supplement 1): 4210.

https://doi.org/10.1182/blood-2023-172953

Published: 2023

Journal Articles

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Jeff Aguilar, Vikram Dhillon, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Julie Boerner, Gregory Dyson, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 6445.

https://doi.org/10.1182/blood-2023-190854

Published: 2023

Journal Articles

Concordance/Discordance of Paired Sequencing of Bone Marrow Tissue and Myeloid Sarcoma Samples- a Meta-Analysis

Dakshin Padmanabhan, Jeff Aguilar, Gregory Dyson, Lakshmi Bhavani Potluri, Vikram Dhillon, Sushmitha Nanja Reddy, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 6013.

https://doi.org/10.1182/blood-2023-190860

Published: 2023

Journal Articles

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Lakshmi Bhavani Potluri, Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Dakshin Padmanabhan, Gregory Dyson, Julie Boerner, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 1853.

https://doi.org/10.1182/blood-2023-191277

Published: 2023

Journal Articles

Picasso: An Open-Source Machine Learning Schema for Annotating Images in Hematology

Vikram Dhillon, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 7854–7855.

https://doi.org/10.1182/blood-2022-171089

Published: 2022

Journal Articles

Molecular Patterns Identify Distinct Subclasses of Myeloid Neoplasia

Blood (2022) 140 (Supplement 1): 6881–6883.

https://doi.org/10.1182/blood-2022-165603

Published: 2022

Journal Articles

Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors

Ali Al Sbihi, Sushmitha Nanja Reddy, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Abdul Moiz Khan, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 6189–6190.

https://doi.org/10.1182/blood-2022-171131

Published: 2022

Journal Articles

New Approaches to Chronic Idiopathic Neutropenia in the Era of Clonal Hematopoiesis

Olisaemeka Ogbue, Tariq Kewan, Waled Bahaj, Carmelo Gurnari, Valeria Visconte, Suresh Kumar Balasubramanian, Bhumika J. Patel, Alan Lichtin, MD, Hetty E. Carraway, Jaroslaw P. Maciejewski

Blood (2022) 140 (Supplement 1): 2916–2917.

https://doi.org/10.1182/blood-2022-163808

Published: 2022

Journal Articles

Intense Immunosuppressive Therapy (anti-thymocyte globulin, alemtuzumab) As Salvage Therapy in Refractory T-Cell Large Granular Lymphocytic Leukemia and Pure Red Cell Aplasia

Fauzia Ullah, Danai Dima, Carmelo Gurnari, Suresh Kumar Balasubramanian, Olisaemeka Ogbue, Hussein Awada, Naomi Kawashima, Najiullah Omar, Swapna Thota, Hetty E. Carraway, Valeria Visconte, Jaroslaw P. Maciejewski

Blood (2022) 140 (Supplement 1): 5795–5796.

https://doi.org/10.1182/blood-2022-163663

Published: 2022

NARROW

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Cryo-EM structure and functional basis of prothrombin recognition by a type I antiprothrombin antiphospholipid antibody

Prevalence, Domain Specificity, and Residue Specificity of IgG, IgM, and IgA Anti-β2GPI Antibodies in Tetra-Positive Antiphospholipid Syndrome Patients: Identification of Two Non-Overlapping Epitopes in Domain I of β2GPI

Epigenetic Age Acceleration in Hematological Malignancies: Beyond Chronological Age, Clinical Implications, and Therapeutic Perspectives

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Clinical and Molecular Characteristics of NPM1 MT De Novo AML ( NPM1 MT dnAML) Differ from NPM1 MT therapy-associated AML ( NPM1 MT tAML)

Automated Peripheral Smear Recognition and Classification of LGL Leukemia Using Machine Learning

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Pomab a Novel Monoclonal Type-I Antiphospholipid Antibody, Reduces Thrombin Generation By Selectively Binding to the Open Form of Prothrombin

Meta-Analysis of Clinicopathological and Biological Characteristics of Myeloid Sarcoma

The Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit the Growth of MLL-r AML

Evaluation of Treatment Outcomes in Adults with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Review and Meta-Analysis

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Concordance/Discordance of Paired Sequencing of Bone Marrow Tissue and Myeloid Sarcoma Samples- a Meta-Analysis

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Picasso: An Open-Source Machine Learning Schema for Annotating Images in Hematology

Molecular Patterns Identify Distinct Subclasses of Myeloid Neoplasia

Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors

New Approaches to Chronic Idiopathic Neutropenia in the Era of Clonal Hematopoiesis

Intense Immunosuppressive Therapy (anti-thymocyte globulin, alemtuzumab) As Salvage Therapy in Refractory T-Cell Large Granular Lymphocytic Leukemia and Pure Red Cell Aplasia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only